Exonate has appointed Olav Hellebø as Chief Executive Officer (CEO). Hellebø brings extensive business and scientific ...

Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals in a deal worth around $10.0bn. Crinetics is a global ...

Boehringer Ingelheim’s Jascayd (nerandomilast) tablets have been granted marketing authorisation by the Medicines and ...

Alignment is not proven by whether teams are coordinated, it is proven by whether their combined efforts are sustained ...

The UK’s challenge is less about capability and more about how well it aligns with the way global pharma now operates ...

Ipsen is set to acquire Memo Therapeutics in a deal worth more than €700m EUR that is focused on potravitug, a phase 2 ...

Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful ...

Launching prescription medicines excellently – achieving optimal commercial performance that reflects a medicine’s value and ...

Teva Pharmaceutical has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) seeking approval ...

Women in Healthcare Leadership podcast series. Now on its fourth series, “Hear from Her” has established itself globally as ...

Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences ...

In the emerging framework, a medicine’s value will increasingly depend on how effectively care is delivered around it’ ...